201 Results

People

  1. Kris
    Kris
  2. Riely
    Riely
  3. Rusch
    Rusch
  4. Ladanyi
    Ladanyi
  5. Drilon
    Drilon
  6. Miller
    Miller
  7. Hellmann
    Hellmann
  8. Gralla
    Gralla
  9. Li
    Li
  10. Sima
    Sima

Groups

  1. Department of Medicine (201)
  2. Solid Tumor Oncology Division (201)
  3. Thoracic Oncology (201)
  4. GSK Faculty (62)
  5. Human Oncology and Pathogenesis Program (53)
  6. Surgery (51)
  7. Epidemiology and Biostatistics (50)
  8. Tow Center for Developmental Oncology (TCDO) (47)
  9. Biostatistics Service (46)
  10. Survivorship Research (31)
  1. "major clinical study"
  2. "Thoracic Oncology"
Formats
  1. Journal Article (197)
  2. Conference Paper (4)
Groups
  1. Department of Medicine (201)
  2. Solid Tumor Oncology Division (201)
  3. Thoracic Oncology (201)
  4. GSK Faculty (62)
  5. Human Oncology and Pathogenesis Program (53)
  6. Surgery (51)

More Groups

People
  1. Mark Kris (92)
  2. Gregory Riely (51)
  3. Marc Ladanyi (44)
  4. Valerie Rusch (30)
  5. Alexander Drilon (23)
  6. Vincent Miller (22)

More People

Years
  1. 2024 (7)
  2. 2023 (10)
  3. 2022 (15)
  4. 2021 (7)
  5. 2020 (26)
  6. 2019 (15)

More Years

Publications
  1. Journal of Thoracic Oncology (19)
  2. Journal of Clinical Oncology (18)
  3. Clinical Cancer Research (17)
  4. Cancer (13)
  5. Lancet Oncology (9)
  6. Annals of Oncology (8)

More Publications

Publishers
  1. Elsevier Inc. (37)
  2. American Society of Clinical Oncology (24)
  3. American Association for Cancer Research (23)
  4. Elsevier Science, Inc. (17)
  5. Wiley Blackwell (17)
  6. Oxford University Press (13)

More Publishers

Results (201)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Brief report: Updated efficacy and safety data from an integrated analysis of entrectinib in locally advanced/metastatic ROS1 fusion-positive non–small-cell lung cancer
    Journal Article

    Fan, Y.; Drilon, A.; Chiu, C. H.; Loong, H. H. F.; Siena, S.; Krzakowski, M.; Dziadziuszko, R.; Zeuner, H.; Xue, C.; Krebs, M. G.
    Clinical Lung Cancer (2024)

    Fulltext@MSK | Save
  • Comparison of immunohistochemistry, next-generation sequencing and fluorescence in situ hybridization for detection of MTAP loss in pleural mesothelioma
    Journal Article

    Febres-Aldana, C. A.; Chang, J. C.; Jungbluth, A. A.; Adusumilli, P. S.; Bodd, F. M.; Frosina, D.; Geronimo, J. A.; Hernandez, E.; Irawan, H.; Offin, M. D.; more...
    Modern Pathology (2024)

    Fulltext@MSK | Save
  • Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): An open-label, randomised, controlled, phase 2 study
    Journal Article

    Tsai, C. J.; Yang, J. T.; Shaverdian, N.; Patel, J.; Shepherd, A. F.; Eng, J.; Guttmann, D.; Yeh, R.; Gelblum, D. Y.; Namakydoust, A.; more...
    Lancet (2024)

    Fulltext@MSK | Save
  • Microsatellite instability and mismatch repair deficiency define a distinct subset of lung cancers characterized by smoking exposure, high tumor mutational burden, and recurrent somatic MLH1 inactivation
    Journal Article

    Yang, S. R.; Gedvilaite, E.; Ptashkin, R.; Chang, J.; Ziegler, J.; Mata, D. A.; Villafania, L. B.; Nafa, K.; Hechtman, J. F.; Benayed, R.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Phase 1/2 study of monalizumab plus durvalumab in patients with advanced solid tumors
    Journal Article

    Patel, S. P.; Alonso-Gordoa, T.; Banerjee, S.; Wang, D.; Naidoo, J.; Standifer, N. E.; Palmer, D. C.; Cheng, L. Y.; Kourtesis, P.; Ascierto, M. L.; more...
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Clinical outcomes of stereotactic body radiation therapy for malignant pleural mesothelioma
    Journal Article

    Shin, J. Y.; Offin, M.; Simone, C. B. 2nd; Zhang, Z.; Shepherd, A. F.; Wu, A. J.; Shaverdian, N.; Gelblum, D. Y.; Gomez, D. R.; Sauter, J. L.; more...
    Radiotherapy and Oncology (2024)

    Fulltext@MSK | Save
  • Repotrectinib in ROS1 fusion-positive non-small-cell lung cancer
    Journal Article

    Drilon, A.; Camidge, D. R.; Lin, J. J.; Kim, S. W.; Solomon, B. J.; Dziadziuszko, R.; Besse, B.; Goto, K.; de Langen, A. J.; Wolf, J.; more...
    New England Journal of Medicine (2024)

    Fulltext@MSK | Save
  • Diagnosis, testing, treatment, and outcomes among patients with advanced non-small cell lung cancer in the United States
    Journal Article

    Yang, M.; MacEwan, J. P.; Boppudi, S. S.; McClain, M. R.; O'Hara, R. M. Jr; Paik, P. K.
    Cancer Medicine (2023)

    Fulltext@MSK | Save
  • Clinical decision support for chemotherapy-induced neutropenia using a hybrid pharmacodynamic/machine learning model
    Journal Article

    Hughes, J. H.; Tong, D. M. H.; Burns, V.; Daly, B.; Razavi, P.; Boelens, J. J.; Goswami, S.; Keizer, R. J.
    CPT: Pharmacometrics and Systems Pharmacology (2023)

    Fulltext@MSK | Save
  • Health utility analysis of tepotinib in patients with non-small cell lung cancer harboring MET exon 14 skipping
    Journal Article

    Yang, M.; Vioix, H.; Hook, E. S.; Hatswell, A. J.; Batteson, R. L.; Gaumond, B. R.; O'Brate, A.; Popat, S.; Paik, P. K.
    Value in Health (2023)

    Fulltext@MSK | Save